Technology
Health
Pharmaceutical

Intersect ENT

$25.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (0.12%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Intersect ENT and other stocks, options, ETFs, and crypto commission-free!

About

Intersect ENT, Inc. Common Stock, also called Intersect ENT, is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Read More The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Employees
393
Headquarters
Menlo Park, California
Founded
2003
Market Cap
804.29M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
360.62K
High Today
$26.46
Low Today
$25.42
Open Price
$25.42
Volume
161.10K
52 Week High
$42.95
52 Week Low
$24.39

Collections

Technology
Health
Pharmaceutical
2014 IPO
US
North America
Female CEOs

News

Yahoo FinanceMay 14

Steven Cohen Dives Deeper Into Intersect ENT

- By Sydnee Gatewood Billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed on May 10 that he expanded his stake in Intersect ENT Inc. (XENT) by 221.55%. The guru's Connecticut-based hedge fund seeks to generate superior risk-adjusted returns using long, short, macro and systematic strategies. According to GuruFocus Real-Time Picks, a Premium feature, Cohen invested in 1.16 million shares of the California-based medical devices manufacturer on May 9. ...

60
Yahoo FinanceMay 13

Abiomed and Intersect ENT Stumble to Start 2019

Med-tech stocks like Abiomed (NASDAQ: ABMD) and Intersect ENT (NASDAQ: XENT) have been red hot in recent years. However, both of these businesses recently failed to live up to investors' expectations. In this episode of The Motley Fool's Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi discuss what went wrong for both of these companies and whether the businesses can recover. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A...

100
Yahoo FinanceMay 8

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Intersect ENT, Inc. Investors (XENT)

BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces an investigation on behalf of Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (NASDAQ: XENT) investors concerning the Company and its officers’ possible violations of federal securities laws. On May 6, 2019, the Company disclosed a first quarter loss of $10.8 million, as well as a lowered guidance for the remainder of 2019. In addition to this news, the Company also reported that its CEO of 11 years will be stepping down on J...

73

Earnings

-$0.35
-$0.27
-$0.19
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.30 per share
Actual
-$0.35 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.